Start the conversation
Investors hate uncertainty. If the future of a business or industry is in question, stocks suffer.
That's certainly the case with the biotech sector right now. In 2019, biotech stocks have been pummeled. The Nasdaq Biotech Index is down almost 12% over the last six months.
What's holding back the group? Uncertainty about drug prices is a huge overhang for biotech stocks